Carlo Minetti

Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy.

J. Engelman, F. Sotgia, M. Lisanti, 1998, American journal of human genetics.

Caveolin-3 directly interacts with the C-terminal tail of beta -dystroglycan. Identification of a central WW-like domain within caveolin family members.

F. Sotgia, M. Lisanti, M. Sudol, 2000, The Journal of biological chemistry.

Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy.

F. Sotgia, M. Lisanti, C. Minetti, 1999, Biochemical and biophysical research communications.

Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype.

S. Fine, M. Lisanti, C. Minetti, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Phosphofructokinase muscle-specific isoform requires caveolin-3 expression for plasma membrane recruitment and caveolar targeting: implications for the pathogenesis of caveolin-related muscle diseases.

S. Woodman, F. Sotgia, M. Lisanti, 2003, The American journal of pathology.

Mutation in the CAV3 gene causes partial caveolin-3 deficiency and persistent elevated levels of serum creatine kinase

F. Zara, M. Lisanti, C. Bruno, 2000, Neurology.

Familial isolated hyperCKaemia associated with a new mutation in the caveolin-3 (CAV-3) gene

M. Lisanti, P. Sabatelli, I. Carbone, 2002, Journal of neurology, neurosurgery, and psychiatry.